PD-L2 induction on dendritic cells exposed to Mycobacterium avium downregulates BCG-specific T cell response

Tuberculosis

Volumn 91, Issue 1, 2011, Pages 36-46

  Mendoza Coronel, Elizabeth ^a   Camacho Sandoval, Rosa ^b   Bonifaz, Laura C ^b   López Vidal, Yolanda ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Dendritic cells; Innate immunity; M. avium; M. bovis BCG; T cells

Indexed keywords

BCG VACCINE; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE P38; PROGRAMMED DEATH 1 LIGAND 2; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; IMMUNE RESPONSE; LUNG TUBERCULOSIS; LYMPHOCYTE ACTIVATION; MALE; MOLECULAR INTERACTION; MOUSE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DOWN-REGULATION; INTERLEUKIN-10; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MYCOBACTERIUM AVIUM; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; TUBERCULOSIS, PULMONARY;

EID: 79551483023     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2010.11.008     Document Type: Article

References (50)

1. G.A. Colditz, T.F. Brewer, C.S. Berkey, M.E. Wilson, E. Burdick, and H.V. Fineberg Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature Jama 271 1994 698 702
2. C. Dye, S. Scheele, P. Dolin, V. Pathania, and M.C. Raviglione Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project Jama 282 1999 677 686
3. P.A. Orege, P.E. Fine, S.B. Lucas, M. Obura, C. Okelo, and P. Okuku Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya Int J Lepr Other Mycobact Dis 61 1993 542 549
4. J.M. Ponnighaus, P.E. Fine, J.A. Sterne, R.J. Wilson, E. Msosa, and P.J. Gruer Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi Lancet 339 1992 636 639
5. C.F. von Reyn, T.W. Barber, R.D. Arbeit, C.H. Sox, G.T. O'Connor, and R.J. Brindle Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions J Infect Dis 168 1993 1553 1558
6. L. Brandt, J. Feino Cunha, A. Weinreich Olsen, B. Chilima, P. Hirsch, and R. Appelberg Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis Infect Immun 70 2002 672 678
7. T. Kamala, C.N. Paramasivan, D. Herbert, P. Venkatesan, and R. Prabhakar Immune response & modulation of immune response induced in the guinea-pigs by Mycobacterium avium complex (MAC) & M. fortuitum complex isolates from different sources in the south Indian BCG trial area Indian J Med Res 103 1996 201 211
8. B.M. Buddle, B.J. Wards, F.E. Aldwell, D.M. Collins, and G.W. de Lisle Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis Vaccine 20 2002 1126 1133
9. G.W. de Lisle, B.J. Wards, B.M. Buddle, and D.M. Collins The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium Tuberculosis (Edinb) 85 2005 73 79
10. C. Demangel, T. Garnier, I. Rosenkrands, and S.T. Cole Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens Infect Immun 73 2005 2190 2196
11. S.L. Young, L. Slobbe, R. Wilson, B.M. Buddle, G.W. de Lisle, and G.S. Buchan Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination Infect Immun 75 2007 2833 2840
12. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
13. R.M. Steinman, D. Hawiger, and M.C. Nussenzweig Tolerogenic dendritic cells Annu Rev Immunol 21 2003 685 711
14. M.S. Labeur, B. Roters, B. Pers, A. Mehling, T.A. Luger, and T. Schwarz Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage J Immunol 162 1999 168 175
15. B.M. Fu, X.S. He, S. Yu, A.B. Hu, Y. Ma, and L.W. Wu Tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T-regulatory cells Exp Clin Transplant 7 2009 149 156
16. M.B. Lutz, and G. Schuler Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23 2002 445 449
17. Torres-Aguilar H, Aguilar-Ruiz SR, Gonzalez-Perez G, Munguia R, Bajana S, Meraz-Rios MA, et al. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J Immunol; 184:1765-1775.
18. Y. Latchman, C.R. Wood, T. Chernova, D. Chaudhary, M. Borde, and I. Chernova PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nat Immunol 2 2001 261 268
19. M. Bros, F. Jahrling, A. Renzing, N. Wiechmann, N.A. Dang, and A. Sutter A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid Blood 109 2007 3820 3829
20. L. Li, S.P. Li, J. Min, and L. Zheng Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells Immunol Lett 114 2007 38 45
21. G. Ureta, F. Osorio, J. Morales, M. Rosemblatt, M.R. Bono, and J.A. Fierro Generation of dendritic cells with regulatory properties Transplant Proc 39 2007 633 637
22. R.A. Henderson, S.C. Watkins, and J.L. Flynn Activation of human dendritic cells following infection with Mycobacterium tuberculosis J Immunol 159 1997 635 643
23. S.P. Hickman, J. Chan, and P. Salgame Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization J Immunol 168 2002 4636 4642
24. C. Demangel, A.G. Bean, E. Martin, C.G. Feng, A.T. Kamath, and W.J. Britton Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guerin-infected dendritic cells Eur J Immunol 29 1999 1972 1979
25. L. Lei, and J.M. Hostetter Limited phenotypic and functional maturation of bovine monocyte-derived dendritic cells following Mycobacterium avium subspecies paratuberculosis infection in vitro Vet Immunol Immunopathol 120 2007 177 186
26. M. Abe, D. Tokita, G. Raimondi, and A.W. Thomson Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses Eur J Immunol 36 2006 2483 2493
27. J. Idoyaga, J. Moreno, and L. Bonifaz Tumor cells prevent mouse dendritic cell maturation induced by TLR ligands Cancer Immunol Immunother 56 2007 1237 1250
28. A.I. Castillo-Rodal, M. Castanon-Arreola, R. Hernandez-Pando, J.J. Calva, E. Sada-Diaz, and Y. Lopez-Vidal Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis Infect Immun 74 2006 1718 1724
29. M. Rodriguez-Alvarez, G. Mendoza-Hernandez, S. Encarnacion, J.J. Calva, and Y. Lopez-Vidal Phenotypic differences between BCG vaccines at the proteome level Tuberculosis (Edinb) 89 2009 126 135
30. R. Brosch, S.V. Gordon, T. Garnier, K. Eiglmeier, W. Frigui, and P. Valenti Genome plasticity of BCG and impact on vaccine efficacy Proc Natl Acad Sci United State America 104 2007 5596 5601
31. M.B. Lutz, N. Kukutsch, A.L. Ogilvie, S. Rossner, F. Koch, and N. Romani An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow J Immunol Methods 223 1999 77 92
32. K. Inaba, M. Inaba, N. Romani, H. Aya, M. Deguchi, and S. Ikehara Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor J Exp Med 176 1992 1693 1702
33. N. Reiling, A. Blumenthal, H.D. Flad, M. Ernst, and S. Ehlers Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity J Immunol 167 2001 3339 3345
34. L. Sweet, and J.S. Schorey Glycopeptidolipids from Mycobacterium avium promote macrophage activation in a TLR2- and MyD88-dependent manner J Leukoc Biol 80 2006 415 423
35. P.E. Fine, I.A. Carneiro, J.B. Milstien, and C.J. Clements Issues relating to the use of BCG in immunization programmes. A discussion document 1999 WHO Geneva WHO/V&B/99.231-42
36. Buchan GS, Lee R, Wilson M, Slobbe L, Buddle BM, Young SL. Strains of Mycobacterium avium differentially activate human dendritic cells. Immunol Cell Biol; 88:95-98.
37. H. Esquivel-Solis, F. Quinones-Falconi, A. Zarain-Herzberg, R.I. Amieva-Fernandez, and Y. Lopez-Vidal Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis Clin Exp Immunol 158 2009 45 54
38. S. Tsuji, M. Matsumoto, O. Takeuchi, S. Akira, I. Azuma, and A. Hayashi Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors Infect Immun 68 2000 6883 6890
39. J. Uehori, M. Matsumoto, S. Tsuji, T. Akazawa, O. Takeuchi, and S. Akira Simultaneous blocking of human toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guerin peptidoglycan Infect Immun 71 2003 4238 4249
40. F. von Meyenn, M. Schaefer, H. Weighardt, S. Bauer, C.J. Kirschning, and H. Wagner Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guerin by Flt3-ligand generated dendritic cells Immunobiology 211 2006 557 565
41. A. Mansell, R. Smith, S.L. Doyle, P. Gray, J.E. Fenner, and P.J. Crack Suppressor of cytokine signaling 1 negatively regulates toll-like receptor signaling by mediating Mal degradation Nat Immunol 7 2006 148 155
42. N. Vazquez, T. Greenwell-Wild, S. Rekka, J.M. Orenstein, and S.M. Wahl Mycobacterium avium-induced SOCS contributes to resistance to IFN-gamma-mediated mycobactericidal activity in human macrophages J Leukoc Biol 80 2006 1136 1144
43. W. Piao, C. Song, H. Chen, M.A. Diaz, L.M. Wahl, and K.A. Fitzgerald Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling J Leukoc Biol 86 2009 863 875
44. Y. Yanagawa, and K. Onoe Enhanced IL-10 production by TLR4- and TLR2-primed dendritic cells upon TLR restimulation J Immunol 178 2007 6173 6180
45. T.B. Geijtenbeek, S.J. Van Vliet, E.A. Koppel, M. Sanchez-Hernandez, C.M. Vandenbroucke-Grauls, and B. Appelmelk Mycobacteria target DC-SIGN to suppress dendritic cell function J Exp Med 197 2003 7 17
46. K.H. Khoo, J.B. Tang, and D. Chatterjee Variation in mannose-capped terminal arabinan motifs of lipoarabinomannans from clinical isolates of Mycobacterium tuberculosis and Mycobacterium avium complex J Biol Chem 276 2001 3863 3871
47. R.M. Steinman, D. Hawiger, K. Liu, L. Bonifaz, D. Bonnyay, and K. Mahnke Dendritic cell function in vivo during the steady state: a role in peripheral tolerance Ann N Y Acad Sci 987 2003 15 25
48. J.A. Brown, D.M. Dorfman, F.R. Ma, E.L. Sullivan, O. Munoz, and C.R. Wood Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production J Immunol 170 2003 1257 1266
49. J.O. Jurado, I.B. Alvarez, V. Pasquinelli, G.J. Martinez, M.F. Quiroga, and E. Abbate Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis J Immunol 181 2008 116 125
50. Lazar-Molnar E, Chen B, Sweeney KA, Wang EJ, Liu W, Lin J, et al. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc Natl Acad Sci U S A; 107:13402-13407.